Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Labouesse MA"'
Autor:
Marinescu AM; Brain, Wire and Behavior Group, Translational Nutritional Biology Laboratory, Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland., Labouesse MA; Brain, Wire and Behavior Group, Translational Nutritional Biology Laboratory, Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.; Neuroscience Center Zurich, University of Zurich, ETH Zurich, Zurich, Switzerland.
Publikováno v:
Frontiers in neuroscience [Front Neurosci] 2024 Jul 30; Vol. 18, pp. 1437210. Date of Electronic Publication: 2024 Jul 30 (Print Publication: 2024).
Autor:
Labouesse MA; Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland.; Neuroscience Center Zurich, University and ETH Zürich, Zürich, Switzerland.; Department of Health Sciences and Technology, ETH Zürich, Zürich, Switzerland., Wilhelm M; Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland.; Institute for Neuroscience, ETH Zurich, Zurich, Switzerland., Kagiampaki Z; Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland., Yee AG; Department of Pharmacology, University of Colorado School of Medicine, Aurora, CO, USA., Denis R; Department of Pharmacology & Physiology, Faculty of Medicine, SNC and CIRCA Research groups, Université de Montréal, Montréal, QC, Canada.; Department of Neurosciences, Faculty of Medicine, SNC and CIRCA Research groups, Université de Montréal, Montréal, QC, Canada., Harada M; Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland., Gresch A; Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland., Marinescu AM; Department of Health Sciences and Technology, ETH Zürich, Zürich, Switzerland., Otomo K; Department of Health Sciences and Technology, ETH Zürich, Zürich, Switzerland., Curreli S; Optical Approaches to Brain Function Laboratory, Istituto Italiano di Tecnologia, Genova, Italy., Serratosa Capdevila L; Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland., Zhou X; Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland., Cola RB; Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland., Ravotto L; Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland., Glück C; Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland., Cherepanov S; Institute of Cellular and Integrative Neuroscience, University of Strasbourg, Strasbourg, France., Weber B; Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland.; Neuroscience Center Zurich, University and ETH Zürich, Zürich, Switzerland., Zhou X; Eli Lilly and Company, Indianapolis, IN, USA., Katner J; Eli Lilly and Company, Indianapolis, IN, USA., Svensson KA; Eli Lilly and Company, Indianapolis, IN, USA., Fellin T; Optical Approaches to Brain Function Laboratory, Istituto Italiano di Tecnologia, Genova, Italy., Trudeau LE; Department of Pharmacology & Physiology, Faculty of Medicine, SNC and CIRCA Research groups, Université de Montréal, Montréal, QC, Canada.; Department of Neurosciences, Faculty of Medicine, SNC and CIRCA Research groups, Université de Montréal, Montréal, QC, Canada., Ford CP; Department of Pharmacology, University of Colorado School of Medicine, Aurora, CO, USA., Sych Y; Institute of Cellular and Integrative Neuroscience, University of Strasbourg, Strasbourg, France., Patriarchi T; Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland. patriarchi@pharma.uzh.ch.; Neuroscience Center Zurich, University and ETH Zürich, Zürich, Switzerland. patriarchi@pharma.uzh.ch.
Publikováno v:
Nature communications [Nat Commun] 2024 Jul 02; Vol. 15 (1), pp. 5551. Date of Electronic Publication: 2024 Jul 02.
Autor:
Labouesse MA; Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, 10032, USA. marie.labouesse@hest.ethz.ch.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, 10032, USA. marie.labouesse@hest.ethz.ch.; Department of Health, Sciences and Technology, ETH Zurich, 8092, Zurich, Switzerland. marie.labouesse@hest.ethz.ch.; Neuroscience Center Zurich, ETH Zurich and University of Zurich, 8057, Zurich, Switzerland. marie.labouesse@hest.ethz.ch., Torres-Herraez A; Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, 10032, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, 10032, USA., Chohan MO; Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, 10032, USA.; Division of Child and Adolescent Psychiatry, New York State Psychiatric Institute, New York, NY, 10032, USA., Villarin JM; Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, 10032, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, 10032, USA., Greenwald J; Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, 10032, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, 10032, USA., Sun X; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, 10032, USA.; Department of Biomedical Engineering, Columbia University, New York, NY, 10027, USA., Zahran M; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, 10032, USA.; Barnard College, Columbia University, New York, NY, 10027, USA., Tang A; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, 10032, USA.; Columbia College, Columbia University, New York, NY, 10027, USA., Lam S; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, 21224, USA., Veenstra-VanderWeele J; Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, 10032, USA.; Division of Child and Adolescent Psychiatry, New York State Psychiatric Institute, New York, NY, 10032, USA., Lacefield CO; Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, 10032, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, 10032, USA., Bonaventura J; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, 21224, USA.; Departament de Patologia i Terapèutica Experimental, Institut de Neurociències, L'Hospitalet de Llobregat, Universitat de Barcelona, Barcelona, Spain., Michaelides M; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, 21224, USA.; Department of Psychiatry & Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA., Chan CS; Department of Neuroscience, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA., Yizhar O; Departments of Brain Sciences and Molecular Neuroscience, Weizmann Institute of Science, Rehovot, 76100, Israel., Kellendonk C; Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, 10032, USA. ck491@cumc.columbia.edu.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, 10032, USA. ck491@cumc.columbia.edu.; Department of Molecular Pharmacology & Therapeutics, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, 10032, USA. ck491@cumc.columbia.edu.
Publikováno v:
Nature communications [Nat Commun] 2023 Oct 23; Vol. 14 (1), pp. 6712. Date of Electronic Publication: 2023 Oct 23.
Autor:
Labouesse MA; Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY 10032, USA.; Current address: Department of Health, Sciences and Technology, ETH Zurich, and Zurich Neuroscience Center, 8057 Zurich, Switzerland., Torres-Herraez A; Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY 10032, USA.; Equal second-author contribution., Chohan MO; Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.; Division of Child and Adolescent Psychiatry, New York State Psychiatric Institute, New York, NY 10032, USA.; Equal second-author contribution., Villarin J; Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY 10032, USA.; Equal second-author contribution., Greenwald J; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY 10032, USA., Sun X; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY 10032, USA.; Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA., Zahran M; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY 10032, USA.; Barnard College, Columbia University, New York, NY 10027, USA., Tang A; Columbia College, Columbia University, New York, NY 10027, USA., Lam S; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD 21224, USA., Veenstra-VanderWeele J; Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.; Division of Child and Adolescent Psychiatry, New York State Psychiatric Institute, New York, NY 10032, USA., Lacefield C; Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY 10032, USA., Bonaventura J; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD 21224, USA.; Departament de Patologia i Terapèutica Experimental, Institut de Neurociències, Universitat de Barcelona, L'Hospitalet de Llobregat, Catalonia., Michaelides M; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD 21224, USA.; Department of Psychiatry & Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore MD 21205, USA., Chan CS; Department of Neuroscience, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA., Yizhar O; Departments of Brain Sciences and Molecular Neuroscience, Weizmann Institute of Science, Rehovot 76100, Israel., Kellendonk C; Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY 10032, USA.; Department of Pharmacology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.; Lead contact: Christoph Kellendonk.
Publikováno v:
Research square [Res Sq] 2023 Feb 11. Date of Electronic Publication: 2023 Feb 11.
Autor:
Martyniuk KM; Department of Neuroscience, Columbia University, New York, United States.; Department of Psychiatry, Columbia University, New York, United States., Torres-Herraez A; Department of Psychiatry, Columbia University, New York, United States.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, United States., Lowes DC; Department of Psychiatry, Columbia University, New York, United States.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, United States., Rubinstein M; Instituto de Investigaciones en Ingeniería Genética y Biología Molecular, Consejo Nacional de Investigaciones Científicas y Técnicas, and Departamento de Fisiología, Biología Molecular y Celular, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires, Argentina., Labouesse MA; Department of Psychiatry, Columbia University, New York, United States.; Department of Health Science and Technology, ETH Zurich, Schwerzenbach, Switzerland.; Zurich Neuroscience Center, Winterthurerstrasse, Zurich, Switzerland., Kellendonk C; Department of Psychiatry, Columbia University, New York, United States.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, United States.; Department of Molecular Pharmacology and Therapeutics, Columbia University, New York, United States.
Publikováno v:
ELife [Elife] 2022 Jul 20; Vol. 11. Date of Electronic Publication: 2022 Jul 20.
Autor:
Labouesse MA; Department of Psychiatry, College of Physicians and Surgeons, Columbia University, Columbia, NY, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA.; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland., Patriarchi T; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland. patriarchi@pharma.uzh.ch.; Neuroscience Center Zurich, University and ETH Zurich, Zurich, Switzerland. patriarchi@pharma.uzh.ch.
Publikováno v:
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2021 Nov; Vol. 46 (12), pp. 2043-2047. Date of Electronic Publication: 2021 Feb 18.
Autor:
Purves-Tyson TD; Schizophrenia Research Laboratory, Neuroscience Research Australia, Sydney, NSW, 2031, Australia.; School of Psychiatry, University of New South Wales, Sydney, NSW, 2052, Australia., Weber-Stadlbauer U; Institute of Pharmacology and Toxicology, University of Zurich-Vetsuisse, Zurich, Switzerland., Richetto J; Institute of Pharmacology and Toxicology, University of Zurich-Vetsuisse, Zurich, Switzerland., Rothmond DA; Schizophrenia Research Laboratory, Neuroscience Research Australia, Sydney, NSW, 2031, Australia., Labouesse MA; Physiology and Behavior Laboratory, ETH Zurich, Schwerzenbach, Switzerland.; Department of Psychiatry, College of Physicians and Surgeons, Columbia University, 1051 Riverside Drive, NYC, 10032, NY, USA., Polesel M; Institute of Anatomy, University of Zurich, Zurich, Switzerland., Robinson K; Schizophrenia Research Laboratory, Neuroscience Research Australia, Sydney, NSW, 2031, Australia., Shannon Weickert C; Schizophrenia Research Laboratory, Neuroscience Research Australia, Sydney, NSW, 2031, Australia. cyndi@neura.edu.au.; School of Psychiatry, University of New South Wales, Sydney, NSW, 2052, Australia. cyndi@neura.edu.au.; Department of Neuroscience and Physiology, Upstate Medical University, Syracuse, 13210, New York, USA. cyndi@neura.edu.au., Meyer U; Institute of Pharmacology and Toxicology, University of Zurich-Vetsuisse, Zurich, Switzerland. urs.meyer@vetpharm.uzh.ch.; Neuroscience Centre Zurich, University of Zurich and ETH Zurich, Zurich, Switzerland. urs.meyer@vetpharm.uzh.ch.
Publikováno v:
Molecular psychiatry [Mol Psychiatry] 2021 Mar; Vol. 26 (3), pp. 849-863. Date of Electronic Publication: 2019 Jun 05.
Autor:
Labouesse MA; Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY 10032, USA., Cola RB; Anatomy and Program in Neuroscience, University of Fribourg, 1700 Fribourg, Switzerland.; Institute of Pharmacology and Toxicology, University of Zurich, 8057 Zurich, Switzerland., Patriarchi T; Institute of Pharmacology and Toxicology, University of Zurich, 8057 Zurich, Switzerland.; Neuroscience Center Zurich, University and ETH Zurich, 8057 Zurich, Switzerland.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2020 Oct 28; Vol. 21 (21). Date of Electronic Publication: 2020 Oct 28.
Autor:
Labouesse MA; Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY 10032; mal2307@cumc.columbia.edu.; Division of Molecular Therapeutics, College of Physicians and Surgeons, Columbia University, New York, NY 10032.; Department of Health Sciences and Technology, ETH Zurich, 8603 Schwerzenbach, Switzerland., Sartori AM; Department of Health Sciences and Technology, ETH Zurich, 8092 Zurich, Switzerland.; Neuro-Urology, Spinal Cord Injury Center and Research, Balgrist University Hospital, University of Zurich, 8008 Zurich, Switzerland.; Brain Research Institute, University of Zurich, 8057 Zurich, Switzerland., Weinmann O; Institute of Pharmacology and Toxicology, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland., Simpson EH; Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY 10032.; New York State Psychiatric Institute, New York, NY 10032., Kellendonk C; Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY 10032.; Division of Molecular Therapeutics, College of Physicians and Surgeons, Columbia University, New York, NY 10032.; Department of Pharmacology, College of Physicians and Surgeons, Columbia University, New York, NY 10032., Weber-Stadlbauer U; Institute of Pharmacology and Toxicology, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2018 Oct 09; Vol. 115 (41), pp. 10493-10498. Date of Electronic Publication: 2018 Sep 25.
Autor:
Labouesse MA; Physiology and Behavior Laboratory, Swiss Federal Institute of Technology (ETH) Zurich, Schwerzenbach, Switzerland.; Department of Psychiatry, Columbia University, New York City, USA., Polesel M; Institute of Anatomy, University of Zurich, Zurich, Switzerland., Clementi E; Institute of Veterinary Pharmacology and Toxicology, University of Zurich - Vetsuisse, Zurich, Switzerland., Müller F; Institute of Veterinary Pharmacology and Toxicology, University of Zurich - Vetsuisse, Zurich, Switzerland., Markkanen E; Institute of Veterinary Pharmacology and Toxicology, University of Zurich - Vetsuisse, Zurich, Switzerland., Mouttet F; Physiology and Behavior Laboratory, Swiss Federal Institute of Technology (ETH) Zurich, Schwerzenbach, Switzerland., Cattaneo A; Biological Psychiatry Laboratory, IRCCS Fatebenefratelli San Giovanni di Dio, Brescia, Italy.; Stress, Psychiatry and Immunology Laboratory, Department of Psychological Medicine, Institute of Psychiatry, King's College London, London, UK., Richetto J; Institute of Veterinary Pharmacology and Toxicology, University of Zurich - Vetsuisse, Zurich, Switzerland. juliet.richetto@uzh.ch.
Publikováno v:
Scientific reports [Sci Rep] 2018 May 29; Vol. 8 (1), pp. 8344. Date of Electronic Publication: 2018 May 29.